Prof. Laurent Derré
University of Lausanne, Switzerland
BBN mouse model of bladder cancer that recapitulates human NMIBC accurately. Confirms dose, schedule and efficacy.
About Us
Academic network
A research collaboration network spanning four countries.
Each partnership accelerates a different question about HSV5-15 - model fidelity, tumour types, or delivery technology.
Prof. Madhuri Koti
Queen's University, Ontario
BBN mouse model studies enabling head-to-head comparison with BCG and underlying immune-mechanism dissection.
Dr Nicola Annels & Dr Guy Simpson
University of Surrey, UK
HSV5-15 in prostate cancer and combination strategies with cancer vaccines.
Fiona Errington-Mais
University of Leeds, UK
HSV5-15 treatment of sarcomas, plus development of new methods of local virus delivery.
Prof. Munitta Muthana & Dr Faith Howard
NANOncolytics, UK
Novel nano-particle delivery technology for HSV5-15 in murine breast cancer.
Prof. Alan Melcher
Institute of Cancer Research, UK
Translational immunology partner across breast cancer and other solid-tumour indications.